The Coronavirus in America: The Year Ahead
- 1 å°å ¥éš
- 2 ãã¯ã€ãããŠã¹ã瀺ããæ°å€ãããå€ãã®ã¢ã¡ãªã«äººã亡ããªããããããªã
- 3 éœåžå°éã¯ãã€ãã¯çµããã ããããã ãçŽäœæ²æãçµãäžã§
- 4 å ç«ãæã€äººã¯ç€ŸäŒçã«æå©ã«ãªã
- 5 ãŠã€ã«ã¹ã®æææ¡å€§ãæå¶ãç¶ããã«ã¯ãç©çã»äººçè³æºã®æ¡å ãäžå¯æ¬ ã
- 6 ã¯ã¯ãã³ã¯ããã«ã¯å®çšåãããªãã ãã
- 7 æ²»çæ³ã®æ¹ãã¯ã¯ãã³ãããå ã«éçºããããã
- 8 ããã°ãã¢ã¡ãªã«ã»ãã¡ãŒã¹ãã
å°å ¥éš
20人以äžã«åã¶å°éå®¶ããæã ãå ã®ç掻ã«ããã«æ»ãå¯èœæ§ã¯ãªãã ãããšè¿°ã¹ãŠãããããããçŸåšçŽé¢ããŠããèŠé£ãšé·ãç®ã§èŠãèŠé£ã«ã¯ãã©ãã«ãé©å¿ã§ããåžæããªãããã§ã¯ãªãã
æ°åã³ãããŠã€ã«ã¹ã¯ã¢ã¡ãªã«ã®å€§éœåžããéå€ã«ãŸã§åºãã£ãŠãããã€ãã«ç°èã«ãŸã§å°éãã¯ãããããã®ãŠã€ã«ã¹ã¯æ°çŸäžäººã«ææãã34,000人以äžãæ»äº¡ãããšããããŠããã
ãããããã©ã³ã倧統é ã¯ä»é±ãçµæžæŽ»åãåéããããã®ã¬ã€ãã©ã€ã³ãæåºããã¢ã¡ãªã«ã®å€§éšåã®å°åãè¿ããã¡ã«éåžžã«è¿ãç¶æ ã«å埩ãããšè¿°ã¹ããç®äžæ°é±éã®éããã®å±æ©ãšæã ã®å°æ¥ã«å¯Ÿããæ¿æš©ã®èŠè§£ã¯ãæ¿æš©ã®é¡§åå»åž«ãç§åŠè äžè¬ã®èŠè§£ãšæ¯ã¹ãŠããã©è²ã®ãè±çã®ããã«éåãšæ¥œèгçã§ããã
å®éã«ã¯ããã®æ°åã³ãããŠã€ã«ã¹ã«ãã屿©ã«ãã£ãŠä»åŸäžçãã©ã®ããã«ãªã£ãŠããã®ãã誰ã«ãåãããªããå ¬è¡è¡çãå»åŠãç«åŠãæŽå²ã®å°éå®¶20人以äžãã詳现ãªã€ã³ã¿ãã¥ãŒã®ãªãã§èªèº«ã®èŠè§£ãæ«é²ãããç§ãã¡ã¯ãã€å€åºèªç²ããè§£æŸãããã ãããïŒæå¹ãªæ²»çæ³ã®ç¢ºç«ãã¯ã¯ãã³ã®éçºãŸã§çŸå®çã«ã¯ã©ã®ããããããã ãããïŒãŠã€ã«ã¹ãå¯ãä»ããªãããã«ããã«ã¯ã©ãããã¹ãã ãããïŒ
ã¢ã¡ãªã«äººã¯ã²ãšãã³èœåãçºæ®ããã°ã嵿工倫ã«ãããã®èŠé£ãä¹ãè¶ããããã«å€§ããªã鲿©ãéããã ãããšèãã人ããããåé²ããããã®éçã¯ç¢ºãã«å°é£ã§ã¯ããããå®è¡å¯èœãªå¯Ÿçãç²ã ãšè¡ã£ãŠããããã©ããã«ããã£ãŠãããæ³šææ·±ãæéå·®ãèšããªããã®éœåžå°éã®è§£é€ãåºç¯å²ã®æ€æ»ãšç¶æ³ã®ç£èŠãæå¹ãªæ²»çã®ç¢ºç«ãå»çåŸäºè ãžã®ååãªå»çç©è³ã®ç¢ºä¿ããããŠããããã¯æå¹ãªã¯ã¯ãã³ã®éçºãå¿ èŠã§ããã
äŸç¶ãšããŠãä»åŸäžå¹Žã®ç¶æ³ã«å¯Ÿããæ²èŠ³çãªäºæž¬ãé¿ããããšã¯äžå¯èœã ããã©ã³ã倧統é ãæ¯æ¥éãããèšè äŒèŠã§å±éãç¶ããŠããã·ããªãª–éœåžå°éã¯éããªãçµäºããã ããããŠã€ã«ã¹ãã身ãå®ãããã®è¬ãããããåºæ¥äžããã ããããµãã«ãŒã¹ã¿ãžã¢ã ãã¬ã¹ãã©ã³ã¯è¿ããã¡ã«äººã ã§æº¢ããããã ãã–ã¯å€¢ç©èªã§ãããšå€§å€æ°ã®å°éå®¶ã¯è¿°ã¹ãŠããã
ãæã ã¯é°é¬±ãªæªæ¥ã«çŽé¢ããŠãããããšåå šç±³å»åŠã¢ã«ãããŒé·ã§ããHarvey V. Finebergå士ã¯èšãã
圌ãšãã®ã»ãã®å°éå®¶ã¯ã人ã ãã€ã©ã€ã©ããªããäœã¶æãå®¶ã®äžã«éã蟌ããããçæŽ»ãéãããšã«ãªãã§ããããäžã§ãææãããšéçåãããã匱è ã¯é颿éããã£ãšé·ããªãã§ãããããšããããšãèŠè¶ããŠãããå°éå®¶ãã¡ã¯ããŠã€ã«ã¹ã®è åšã«æãããç¶æ ãé·æåãããã®ç¶æ ã«ç²ãåã£ãåœæ°ãå±éºæ§ãé¡§ã¿ãã«èŠå¶ãæ€å»ããå®å šæ§ã確ãããããŠããªãã¯ã¯ãã³ãç§åŠè ã®å¶æ¢ãæ¯ãåã£ãŠäœ¿çšãããã®ã§ã¯ãªãããšæžå¿µããŠããã
ãæ¥œèгçãªããšãè¿°ã¹ããªãããŠã€ã«ã¹ã®ææã¯å€ã«ã¯èœã¡çããã¯ã¯ãã³ãéšå µéã®åŠãåºæ¥äžãã£ãŠãŠã€ã«ã¹ãé§éããã ãããããšäºé²å»åŠã®å°éå®¶ã§ãããŽã¡ã³ããŒãã«ã倧åŠå»åŠéšã®William Schaffnerå士ã¯èšããããã ãç§ã¯æ ¹æ¬çã«æ¥œèгçãªçæ¥ã®æ°è³ªãæããããšãåŠãã§ããæäžã ãã
倧åã®å°éå®¶ã¯ãã²ãšãã³å±æ©çç¶æ³ãè±ããã°ãåœå®¶ãšãã®çµæžã¯ããããŸæ¯ãå¹ãè¿ããšä¿¡ããŠãããããããæ¿çããéãããã¹ã¯ãªãã ããã
äžççãªææççºãããã«ããŠåæãããã¯ãéšåçã«ã¯ãæªã 蚪ããŠããªãå»åŠã®é²æ©ã«ããã£ãŠãããããã«ãã¢ã¡ãªã«äººäžäººäžäººããã®éçšã«ãããŠã©ã®ããã«è¡åãããã«ãããã£ãŠãããããæã ãæãèº«ãšæããäººãææ°ã®æ³šæãæã£ãŠææããå®ããªãã°ãããå€ãã®äººãçãæ®ãã ãããããæã ããŠã€ã«ã¹ãçãèŠãã°ããŠã€ã«ã¹ã¯å®¹æã«ææãã¹ãè ãèŠã€ãåºãã ããã
ãã¯ã€ãããŠã¹ã瀺ããæ°å€ãããå€ãã®ã¢ã¡ãªã«äººã亡ããªããããããªã
æ°åã³ãããŠã€ã«ã¹ã«ãã£ãŠåŒãèµ·ããããææçã§ããCovid-19ã¯ãçŸåšïŒ4æ18æ¥ïŒã§ã¯ãŸãééããªãã¢ã¡ãªã«äººã®äž»èŠãªæ»å ã§ããã4æ12æ¥ä»¥æ¥ããã®ãŠã€ã«ã¹ã«ãã£ãŠã»ãŒæ¯æ¥1,800人以äžã®ã¢ã¡ãªã«äººã亡ããªã£ãŠãããå ¬åŒçºè¡šã®æ»è æ°ã¯å®éããå°ãªãã®ã§ã¯ãªãã ããããšããããŠããã
åèãŸã§ã«ãã¢ã¡ãªã«äººã®äžæ¥ãããã®å¿èç ã«ããæ»è æ°ã¯æŠã1,774人ãçã«ããæ»è æ°ã¯1,641人ã§ããã
確ãã«ãæ°åã³ãããŠã€ã«ã¹æ£è æ°ã®äžæã¯éåããŠãããææççºã®äžå¿å°ã§ãããã¥ãŒãšãŒã¯ã«ãããå ¥é¢æ£è æ°ãæžå°ããŠããããICUå ã®æ£è æ°ãæžå°ããŠãããæ¥ã ã®æ»è æ°ã¯äŸç¶ãšããŠæ®é ·ãªã»ã©å€ããããã§ã«äžæ¥ãããã®æ»è æ°ã®å¢å ã¯åãŸã£ãŠããã
ãããã¯ã€ãããŠã¹ã«åŒçšãããã¯ã·ã³ãã³å€§åŠä¿éºææšè©äŸ¡ç ç©¶æïŒInstitute for Health Metrics and EvaluationïŒIHMEïŒãäœæããŠããç«åŠã¢ãã«ã§ã¯ãåœåã¯6æäžæ¬ãŸã§ã«æ»è ã100,000ïœ240,000人ã«éãããšäºæ³ããŠãããããããçŸæç¹ã§ã®äºæ³æ»è æ°ã¯60,000人ã«ä¿®æ£ãããŠããã
æ»è æ°ãåœåã®äºæ³ãããäœããªã£ãã®ã¯åã¶ã¹ãããšã ããã ãããšãã£ãŠéèŠãªæžå¿µãå¿ããŠã¯ãªããªãããã®ç ç©¶æã®äºæž¬ã¯8æ4æ¥ãŸã§ã§ããããã®ææçã®æµè¡ã®ç¬¬äžæ³¢ããè©äŸ¡ããŠããªããã¯ã¯ãã³ãå®çšåãããªããã°ããŠã€ã«ã¹ã¯æ°å¹Žã«æž¡ã£ãŠåå°ã§çåšãæ¯ããç¶ããæ»è æ°ã¯æéãšãšãã«å¢ããŠããã ããã
çŸæç¹ãŸã§ã®ææã¯åœäžãå°éããããšã«ãã£ãŠããããããŠããããã®ç¶æ³ã¯ç¡æéã«ç¶ãããããã®ã§ã¯ãªãããã¯ã€ãããŠã¹ã®ã段éçãå°éè§£é€èšç»ã¯ãã©ãã»ã©ç¶¿å¯ã«å®è¡ããããšããã§ã確å®ã«æ»è æ°ãå¢å ãããã ããããã®èšç»ãå®è¡ãããäžã§æãæãŸããã®ã¯æ»è æ°ãæå°éã«æããããšã ã
ä»åŸã©ãã»ã©ã®ã¢ã¡ãªã«äººã亡ããªããã«é¢ããä¿¡é Œæ§ã®é«ãé·æã«ãããäºæž¬ã¯æ§ã ãªãã®ãããããã©ããæ®é ·ãªã»ã©å€ãæ°å€ã§ããã3æã«çŸç 管çäºé²ã»ã³ã¿ãŒïŒCenters for Disease Control and PreventionïŒCDCïŒã«æèŠãæ±ãããã倿¹é¢ã®å°éå®¶ãã¡ã¯ãããæææ¡å€§ãé²ãããã®ãªãã®æç«ãŠãè¬ããããªããã°ãã¢ã¡ãªã«äººå šäœã®48ïœ65ïŒ ãæ°åã³ãããŠã€ã«ã¹ã«ææããèŽæ»çã¯ãããã«1ïŒ ãäžåãçšåºŠã§ãæå€§170äžäººã亡ããªãã ããããšããäºæž¬ãåºããã
3æ30æ¥ã«å€§çµ±é ãåŒçšããã€ã³ããªã¢ã«ã»ã«ã¬ããžã»ãã³ãã³ã®ç ç©¶è ã«ããäºæž¬ã¢ãã«ã§ã¯ãåæ§ã®ç¶æ³äžã§ã¯9æãŸã§ã«220äžäººã®ã¢ã¡ãªã«äººã亡ããªããšãããŠããã
åèãŸã§ã«ãç¬¬äºæ¬¡äžç倧æŠã§äº¡ããªã£ãã¢ã¡ãªã«äººã¯42äžäººã§ããã
æ°åã³ãããŠã€ã«ã¹ã«é¢ããäžåœã®éãããããŒã¿ã«ãããšãç¶æ³ã¯ããäžå±€æããããªãããã§ãããçŸæç¹ã§ã¯äžåœã®æææ¡å€§ã¯èœã¡çããäºå®äžãç¬¬äžæ³¢ã®å šãŠã®ææè ã¯äº¡ããªã£ããããŸãã¯å埩ããã
äžåœã®å ¬åŒçºè¡šã§ã¯ãææè æ°çŽ83,000ãæ»è æ°4,632ã§ãããèŽæ»çã¯5ïŒ ä»¥äžã§ããããã©ã³ãæ¿æš©ã¯ãæ¿æš©ã®ç€ºããŠããäºæž¬èŽæ»çãªã©ã®æ°å€ãçåèŠãããŠããŠããããæ£ç¢ºãªæ°å€ãåºãããšã¯ããŠããªãã
èŽæ»çã¯ãå»ç厩å£ã®åºŠåããšãå®éã®ææè ãã¡ã®ã©ãã ããæ€æ»ãããŠææ¡ãããŠãããã«å€§ããå·Šå³ããããç§åŠçæ ¹æ ã«åºã¥ãå»çã»ã³ã¿ãŒïŒCentre for Evidence-Based MedicineïŒCEBMïŒã®å ±åã«ãããšãæŠæŒ¢ã倧混乱ã«é¥ã£ãŠããïŒæã®æåã®é±ã«ã¯ãäžåœã«ãããèŽæ»çã¯17ïŒ ã ã£ããã2æã®çµããã«ã¯ãã£ãã®0.7ïŒ ã ã£ããšããã
æãåœã§ã¯ããã¥ãŒãšãŒã¯ãå«ãããã€ãã®éœåžã®ç é¢ããå»ç厩å£ã«ãªããã©ããã®ç¬æžéã®ç¶æ ã«ãããæŠæŒ¢åžãšãã¥ãŒãšãŒã¯å·åœå±ã¯ä»é±ãCovid-19ãè³åäžãå¿èçºäœããã®ä»ã®åå ãããã«ã¯ææ¥è»ãåŒãã§ãæ¥ãªãã£ãããã«ãå€ãã®äººãèªå® ã§äº¡ããªã£ãŠããããšãæããã«ãªããæ°åã³ãããŠã€ã«ã¹ã«ããæ»è æ°ãäžæ¹ä¿®æ£ããªããã°ãªããªãã ããã
ç¶æ³ãç®ãŸããããå€åããææçã®å€§æµè¡æã«ãããŠã¯ãå»åž«ãæ€æ»å¯èœãªäººæ°ããããã£ãšå€ãã®æ£è ãç é¢ã«ãªã ã蟌ãã§ããããèªå® ã§æ»äº¡ãããããŠãããåæã«ã軜çãç¡çç¶ã®æ£è ã¯æ€æ»ãããªãããããã®äºã€ã®èŠå ã¯ãçã®èŽæ»çãçéã®æ¹åã«æªãããæ£ç¢ºãªææè æ°ãåãããªããã°ãã©ãã»ã©ã®èŽæ»çã®ãŠã€ã«ã¹ãªã®ãåãããªãã®ã ã
æ°äžåäœã®æäœæ€æ»ã宿œãããŠãã£ãšã¢ã¡ãªã«ã«ãããç¡çç¶ã®ãŠã€ã«ã¹ææè æ°ã®æŠæ°ãææ¡ããããšãã§ããã ãããCDCã¯ãç¡çç¶ã®ææè ã®å²åã¯ãæ€æ»ã§éœæ§ãšãªã£ã人ã®25ïŒ ã»ã©ã§ã¯ãªãããšç€ºåããŠãããã¢ã€ã¹ã©ã³ãã®ç ç©¶è ã¯ããã®äºåã§ã¯ãªãããšè¿°ã¹ãŠããã
äžåœãèªåœã®æŠç®ãä¿®æ£ããŠããã2æã«ã¯ãäž»èŠãªç ç©¶ã«ãã£ãŠãæŠæŒ¢ã®ææè ã®ãã¡ç¡çç¶ã ã£ãã®ã¯ãã£ã1ïŒ ã ã£ããšçµè«ã¥ãããããæ°ããªç ç©¶ã§ã¯ããã®æ°å€ã¯60ïŒ ã«éããã®ã§ã¯ãªãããšãããŠãããæã ããã®ææçã«ã€ããŠç¥ãåŸãæ å ±ã¯ãç«åŠè æ³£ãããªã»ã©å°ãªãã®ã ã
ãã©ã®äºæž¬ã¢ãã«ããã ã®äºæž¬ã¢ãã«ã«ãããªããããšãã¯ã€ãããŠã¹ã®ã³ãããŠã€ã«ã¹å¯Ÿçæ¬éšç§åŠé¡§åã§ããAnthony S. Fauciå士ã¯èšã£ãŠããããæ°ããæ å ±ãåŸãããããäºæž¬ã¢ãã«ã¯å€åããã®ã ãã
ãã®äžè²«æ§ã®ãªãã®äžã«ã¯è¯ããã¥ãŒã¹ãåãŸã£ãŠãããããããªã–ãŠã€ã«ã¹ãåŒ±æ¯æ§ã«å€ç°ãã€ã€ããã®ãããããªããæ ç»ã®äžã§ã¯ãŠã€ã«ã¹ã¯åŒ·æ¯æ§ã«å€ç°ãããã®ã ãã ãå®éã«ã¯ãç¡çç¶ã®åã®ãŠã€ã«ã¹ã®æ¹ã宿䞻ãç²åŸãããããããåŒ·æ¯æ§ã«å€ç°ããããšã¯å€ããªãã1918幎ã®ã¹ãã€ã³ã€ã³ãã«ãšã³ã¶ã§ãããã ãã ããšå£ç¯æ§H1N1ã€ã³ãã«ãšã³ã¶ã«åŒ±æ¯åããŠãã£ãã
çŸæç¹ã§ã¯ãæã ã¯ãã®ãŠã€ã«ã¹ãã©ãã»ã©ææåãé«ããã©ãã»ã©èŽæ»çãé«ããæ£ç¢ºã«åãã£ãŠããªããããããéºäœå®çœ®ã»ç§»éçšã®å·èµãã©ãã¯ãäœå°ãç é¢ã®åã«åãŸã£ãŠããå æ¯ããæã ãå¿ã«çããŠããã¹ãããšãäŒããŠãã–ä»ã®ç¶æ³ã¯é³¥ã€ã³ãã«ãšã³ã¶ã®æµè¡æããããã£ãšæªãã
éœåžå°éã¯ãã€ãã¯çµããã ããããã ãçŽäœæ²æãçµãäžã§
çŸæç¹ãŸã§ã«äœäººã®ã¢ã¡ãªã«äººãææããŠããã®ãã誰ã«ãåãããªããæšå®ã§ã¯3ïŒ ã10ïŒ ãšã°ãã€ãããããããããå°ãªããšãæã ã®ãã¡ã®3åäººã«ææããå±éºãããã®ã¯ééããªãã ããã
æå¹ãªã¯ã¯ãã³ãŸãã¯ãŠã€ã«ã¹ãã身ãå®ãæ¹æ³ãåºçŸãããŸã§ãå€åºèªç²æªçœ®ãå®å šã«è§£é€ã§ããã·ããªãªã¯ãªããšããã®ããç«åŠè ãã¡ã®èãã ã
ãã倧å¢ã®ã¢ã¡ãªã«äººãå€åºèªç²ã«é£œããŠåºæ©ãããããããã3é±éãããã¯äœäºãèµ·ãããªãããã«èŠããã ããã
ãããŠãææ¥æ²»ç宀ããŸãæ£è ã§æº¢ããããç¶æ ã«éæ»ãããã®ã ã
ãããã°ããã®éé¿é£ããŠããã°ãå¿ èŠãªã¯ã¯ãã³ãå®çšåãããŠããã ãããããšãããããªãäžäžã®åªè¡ãã¿ãæ ¹æ ã®ãªãèããæã€äººãããããã ãããšãã€ã©ãŒå»ç§å€§åŠç±åž¯å»åŠåŠé¢é·ã§ããPeter J. Hotezå士ã¯èšãã
Tomas Pueyoæ°ã¯ã3æ19æ¥ã«Mediumã«æçš¿ããéåžžã«æåãªèšäºãCoronavirus: The Hammer and the Danceãã®äžã§ãå šåœçãªéœåžå°éãæ£ç¢ºã«äºæž¬ããŠããã圌ã¯å šåœçãªéœåžå°éããã³ããŒãšåŒã³ããã®åŸã«ãã³ã¹ãšåŒã¶ãæäœé床ã®äººå¡ã«ããåŠæ ¡åéãå·¥å Žå皌åãå«ãçµæžæŽ»ååéã®éèŠãªæ®µéã§ããæ°ããå±é¢ããã£ãŠæ¥ããšè¿°ã¹ãã
ã©ã®ç«åŠã¢ãã«ããã®ãã³ã¹ã«çžåœããå±é¢ãæ³å®ããŠããããã®ã©ããã倧å¢ãéãŸããããªæŽ»åãæŽ»çºåãããã³ã«ãŠã€ã«ã¹ã倧æµè¡ããéœåžå°éãåéããªããã°ãªããªããªããšæ³å®ããŠããããããŠãã®ãµã€ã¯ã«ãç¹°ãè¿ããããç«åŠã¢ãã«ã§ã¯ãæ»è æ°ã®äžäžã衚ãã°ã©ãã¯ãŸãã§ãµã¡ã®æ¯åã®ããã«èŠããã
ç«åŠã¢ãã«ã®äºæž¬ã§ã¯ãã¹ã¿ãžã¢ã ãæäŒãæ ç»é€šãããŒãã¬ã¹ãã©ã³ãééãããŸãŸã«ããæµ·å€ããæ¥ãå šãŠã®å ¥åœè ã»åž°åœè ã14æ¥ééé¢ããæææ¡å€§ãæ¿ããå°åããèœã¡çããŠããå°åãžã®ãããªãæææ¡å€§ãé²ãããã«åœå æ è¡ãå³ããèŠå¶ãããšããŠããæ»è æ°ã®æ¥æ¿ãªäžæã¯é¿ããããªããšããã
èŠå¶ãå³ããã»ã©ãæ»è æ°ã¯å°ãªããªããéœåžå°éãšéœåžå°éã®éã®æéãé·ããªããšå°éå®¶ã¯è¿°ã¹ãŠãããã»ãšãã©ã®äºæž¬ã¢ãã«ããã¢ãžã¢ã®åœã ã§ãã§ã«æ¥åžžçã«è¡ãããŠããããã«ãã¢ã¡ãªã«åè¡åœãããããã¯å€§èŠæš¡ãªäœæž©æ€æ»ãè¿ éæ€æ»ãæ¥è§Šè 远跡調æ»ãè¡ãã ãããšæšæž¬ããŠããã
ãã©ã³ã倧統é ã4æ16æ¥æšææ¥ã«å ¬éãããOpening Up America Againããšããã¬ã€ãã©ã€ã³ã§ãããäžæ®µéã®ç€ŸäŒçè·é¢ã«ã€ããŠæžãããŠãããææãããã人ã¯å€åºèªç²ãç¶ããããšãæšå¥šããŠããããã®èšç»ã§ã¯æ€æ»ãéé¢ãæ¥è§Šè 远跡調æ»ãè¡ãããããšã«ãªã£ãŠããããããããå ·äœçã«ã©ã®ããã«è¡ãããã®ããã©ãã»ã©ã®æéè¡ãããã®ããæç¢ºã«è¿°ã¹ãããŠããªãã
忥ã«å ¬è¡šããã¬ã€ãã©ã€ã³ã®å 容ãšççŸããããšã«ãæ§ããã4æ17æ¥éææ¥ããã©ã³ã倧統é ã¯ãã·ã¬ã³å·ããããœã¿å·ããŽã¡ãŒãžãã¢å·ã®éœåžå°éã«å察ããæè°å£äœãå¿æŽãããã€ãŒããããã
äžåœã¯æŠæŒ¢ãå京ãªã©ã®éœåžã培åºçãªç£èŠäœå¶äžã«çœ®ããæ°èŠææè æ°ããŠã€ã«ã¹ã®æœäŒæéã§ãã14æ¥éé£ç¶ã§0人ã§ãªãéããéœåžå°éã®è§£é€ãèªããªãã£ããäžåœãã€ã¿ãªã¢ã®æªçœ®ã«æ¯ã¹ãŠãã¢ã¡ãªã«ã®æªçœ®ã¯ãŸã åäŸã®éã³ã®ããã§ããã
ã¢ã¡ãªã«äººã¯åœå ç·ãå©çšããããšãã§ããããè¡ããããšããã«è»ã§è¡ãããšãã§ããããè¡ã®éããå ¬åãæ©ãåãããšãã§ãããæ§ã ãªèŠå¶æªçœ®ã«ãé¢ããããåäŸã®ããã«å¯ãã«éã¶èšç»ãç«ãŠãŠãã人ããè£åºã§ããŒããã¥ãŒãããŠãã人ããåºäŒãç³»ã¢ããªã䜿ã£ãŠçžæãæ¢ããŠãã人ãããããšã¯æé»ã®äºè§£ãšãªã£ãŠããã
çµæãšããŠãã¢ã¡ãªã«ã®äžæ¥ã®æ°èŠææè æ°ã30,000人ã«åã¶äžå ãšãªã£ãŠãããSchaffnerå士ã¯ããïŒãã¹ã¯ããããïŒãã³ãããå·»ããŠãããšããŠããéãŸã£ãŠããŒã«ãŒãããã®ã¯å®å šã§ã¯ãªããšèªèŠããå¿ èŠããããããšè¿°ã¹ãŠããã
峿 Œãªæªçœ®ããšã£ãŠããã¢ãžã¢ã®åœã ã§ããããŠã€ã«ã¹ãå¶åŸ¡ããã®ã«ã¯èŠåŽããŠããã
æ¯æ¥100人çšåºŠã®æ°èŠææè ãåºããŠããäžåœã§ã¯ãå ããåã³åœå ã®å šãŠã®æ ç»é€šãééãããã·ã³ã¬ããŒã«ã¯å šãŠã®åŠæ ¡ãšã©ã€ãã©ã€ã³ã«é¢ãããªãè·å Žãééãããæ¥æ¬ã§ã¯ã€ãã«ç·æ¥äºæ 宣èšãçºä»€ããããïŒéåœã¯æææ¡å€§ãšæŠã£ãŠããããæ¥ææ¥ã«ã¯ã€ãã«æ°èŠææè æ°ã8人ãšãªãããã®2ã¶æã§åããŠäžæ¡ã«ãªã£ããïŒ
人åœãå®ããšããæ±ºæã®ããšãåCDCé·ã§ããThomas R. Friedenå士ã«ãã£ãŠéå¶ãããŠããå ¬è¡ç°å¢è¡çæè·å£äœãããã€çµæžæŽ»åã®åéãå¯èœã§ããã€éœåžå°éãããªããã°ãªããªããã«ã€ããŠã®ã詳现ãã€å³æ Œãªåºæºãå ¬è¡šããã
éœåžå°éã®è§£é€ã«ã¯ã14æ¥éã«ãããææè æ°ã®æžå°ã90ïŒ ã®æ¥è§Šè ã远跡å¯èœã§ããããšãå»çåŸäºè ã®ææãåæããããšã軜çè ç逿œèšã®ç¢ºä¿ãããã«ä»ã«ãéæãé£ããæ¡ä»¶ãæºããããšãå¿ èŠã§ããã
ãéœåžå°éã®è§£é€ã¯èå£ãéããããã«åŸã ã«è¡ãã¹ãã§ãããæ°Žéãéããããã«äžæ°ã«è¡ãã¹ãã§ã¯ãªããããšFriedenå士ã¯è¿°ã¹ãŠããããä»ã¯ãéœåžå°éã®è§£é€ãåºæ¥ãã ãæ©æã«å®çŸã§ããããã«åªåãã¹ãæã ãã
å ç«ãæã€äººã¯ç€ŸäŒçã«æå©ã«ãªã
æ°åã³ãããŠã€ã«ã¹ã®ææããå埩ããŠå ç«ãç²åŸãããšæããã人ãšãäŸç¶ãšããŠæ°åã³ãããŠã€ã«ã¹ã«å¯Ÿããå ç«ãæããªã人ã®äºã€ã®éå±€ã«ã¢ã¡ãªã«äººãåãããããšãããã
ãæããã察ç«ãèµ·ããããšã«ãªãã ããããWHOã®Covid-19ç¹äœ¿ã§ããDavid Nabarroå士ã¯äºèšããããæäœãæã£ãŠããäººã¯æ è¡ããããšãåãããšãã§ããŠãæäœãæã£ãŠããªã人ã¯å·®å¥ããããã
ãã§ã«ãå ç«ãç²åŸããŠãããšæããã人ã¯åæ¹é¢ããéèŠããããæäœæ¡åã®ããã®ç®è¡ãé ŒãŸããããææãªã¹ã¯ã®é«ãå»çç³»ã®ä»äºã«èããããšãªãåŸäºã§ãããããŠããã
è¿ããã¡ã«æ¿åºã¯ãå®éã«å ç«ãç²åŸã§ããŠãããã©ããã蚌æããæ¹æ³ãèæ¡ããªããã°ãªããªããªãã ããããžã§ãŒãžã¿ãŠã³å€§åŠæ³ç§å€§åŠé¢ã®äžççæµè¡ç ã®å°éå®¶ã§ããDaniel R. Luceyå士ã¯ãå ç«ã確ç«ããããšç£çãããIgGæäœã®æ€æ»ãæå¹ã ãããšè¿°ã¹ããçŸåšå€ãã®äŒæ¥ãæäœæ€æ»ã®éçºã«åãçµãã§ãããšããã§ããã
ãã¯ã€ãããŠã¹ã¯ãã€ãã§ææ¡ããããããªèšŒææ¹æ³ã«ã€ããŠè°è«ããŠãããšFauciå士ã¯èšã£ãŠãããäžåœã§ã¯ãææè ã®å人æ å ±ãšé¢é£ã¥ããããŠããŠä»äººãåçšããããšã®ã§ããªãã¹ããŒããã©ã³ã®QRã³ãŒãã䜿çšããŠããã
ã«ãªãã©ã«ãã¢æäººæ ç»ç£æ¥çã¯äœå幎ãåãããã®èšŒææ¹æ³ã®å é§è ã§ãã£ãã俳åªãã¡ã¯éå»14æ¥é以å ã«HIVãã¹ãã§é°æ§ã ã£ãããšã蚌æããã®ã«æºåž¯é»è©±ã¢ããªã䜿çšãããããã¥ãŒãµãŒã¯ãã¹ã¯ãŒãã§ä¿è·ããããŠã§ããµã€ãã§ãã®æ å ±ã確èªããããšãã§ããã
éœåžå°éã§ç£çŠç¶æ ã«ããã¢ã¡ãªã«äººããå ç«ãç²åŸããä»ã®ã¢ã¡ãªã«äººã掻åãåéããæãŠã¯èªåã倱ã£ãä»äºã代ããã«åŸãã®ãèŠãã«ãããã£ãŠãèªãé²ãã§ãŠã€ã«ã¹ã«ææãã«è¡ãããšã§èªåã圌ãã®åŽã«åããããšãéåžžã«åŒ·ãè¡åã«é§ãããã ããããšã¯æ³åã«é£ããªãããšå°éå®¶ã¯äºæž¬ããŠãããç¹ã«è¥ãåžæ°ã¯ããã è²§å°åã»å€ç«åããŠããã®ãåŸ ã£ãŠããã ããããéãç æ°ã«ãããå±éºãåãæ¹ããŸã ãŸãã ãšæãã ããã
ãããŒããŒãã®çµæžåŠè ã§ããåšã¯ãèªåãšå幎代ã®äººã ã¯å ç«ãç²åŸãã人ãå¢ããçµæžãåãç¶ããããã«ã³ããããŒãã£ãŒãéãã¹ãã ãšãç§ã«èšãç¶ããŠãããããšã¹ã¿ã³ãã©ãŒã倧åŠã°ããŒãã«ãã«ã¹ã€ãããŒã·ã§ã³ã»ã³ã¿ãŒãäž»å°ããMichele Barryå士ã¯è¿°ã¹ãã
人ã ãææçã«èªãææãã«è¡ãçŸè±¡ã¯ä»¥åã«ããã£ãããã¥ãŒãæ¿åºã¯1980幎代ã«ãéœæ§æ£è ã容赊ç¡ãé颿œèšã«åŒ·å¶çã«ç§»äœãããããšã§ãšã€ãºã®æææ¡å€§ãæã蟌ãããšã«æåãããç§»äœã®åŒ·å¶æªçœ®ãšã¯è£è ¹ã«ãæœèšã®å± äœè ã«ã¯èªåå°çšã®ãã³ã¬ããŒãé£äºãå»çã絊äžãäžããããåå£ãèžè¡ã®ææ¥ã«ãåå ããããšãã§ããã
ã¢ã¡ãªã«ã§ã®Fauciå士ã®ãããªããã¥ãŒãã«ãããAIDSã®å°éå®¶ã§ããJorge Pérez Ãvilaå士ã¯ãäœå人ãã®è¡ãå Žã®ãªãè¥è ãããã®æœèšã«å ¥æããããšããŠãæ§è¡çºãè¡æ¶²æ³šå°ã«ãã£ãŠèªããšã€ãºã«ææãããšè¿°ã¹ãŠããã圌ãã®å€§åã¯æã¬ãããŠã€ã«ã¹çæ³ãå°å ¥ãããåã«äº¡ããªã£ãã
èªå·±ææã¯ã¢ã¡ãªã«ã®è¥è ã«ãšã£ãŠã倧ããªè³ãã§ãããæããã«è¥æºãå ç«äžå šã®äººã«ã¯ãªã¹ã¯ãé«ãããããç©ããŠããŠå¥åº·ãªã¢ã¡ãªã«äººã®è¥è ããã§ã«Covid-19ã«ãã£ãŠäº¡ããªã£ãŠããã
ãŠã€ã«ã¹ã®æææ¡å€§ãæå¶ãç¶ããã«ã¯ãç©çã»äººçè³æºã®æ¡å ãäžå¯æ¬ ã
ä»åŸã®2幎éã¯è©Šè¡é¯èª€ã®æéã«ãªãã ããããšå°éå®¶ã¯è¿°ã¹ãŠãããå ç«ãç²åŸãã人ã ãä»äºã«åŸ©åž°ããã°ããã»ã©ãçµæžãå埩ããã ããã
ããããããŸãã«å€ãã®äººãäžåºŠã«ææãããããããªãéœåžå°éãé¿ããããªãã ããããããé¿ããã«ã¯ãåºç¯å²ã«ãããæ€æ»ãå¿ é ã ããã
Fauciå士ã¯ããã€æææ¡å€§ãåæãããã¯ããŠã€ã«ã¹ãæããŠãããã ãããããšèšããããã¯ã€ãŸããäžæ¥ãããã®è©Šéšæ°ãæäœæ°åäžä»¶ãšããå šåœå ±éã®åºæºã確ç«ãããåœå šäœã§é©çšãããããã«ãªãã°ãéœæ§ã®å²åãäžæããŠããå°åã§ãŠã€ã«ã¹ãåºãã£ãŠããããšãããã«åããããã«ãªããæææ¡å€§å°åãšéæ¡å€§å°åãèŠåãããããšããããšã ã
Kinsaã®ã¹ããŒãäœæž©èšã®ããŒã¿ããäœæãããçºç±ã¬ãã«ã«ãã£ãŠè²åããããå°å³ãèŠãã°ãäœæž©ã®äžæå ·åããæææ¡å€§ã®å åãæ©æã«çºèŠããããšãã§ããããšSchaffnerå士ã¯è¿°ã¹ãã
ããããèšºææ€æ»ã¯åããããã©ãã«ã«èŠèããç¶ããããã¯ã€ãããŠã¹ã¯è¿ 鿀æ»ããããååçšæãããšç¢ºçŽããã«ãé¢ããããå»åž«ãšæ£è ããæ€æ»ãããã®äžè¶³ãšæºåã®é ãã«äžæºãåŽåºããã
ãŠã€ã«ã¹ãæå¶ãç¶ããããã«ã¯ãã¢ã¡ãªã«ã§ã軜çè ãå«ãå šãŠã®ææè ã®éé¢ã宿œãå§ããªããã°ãªããªãããšäœäººãã®å°éå®¶ã䞻匵ããŠããã
ã¢ã¡ãªã«ã§ã¯ãæ€æ»ã§éœæ§ãšãªã£ãæ£è ã¯èªå® åŸ æ©ãèŠè«ãããããå®¶æãšã®æ¥è§Šãé¿ããããšãæ±ããããŠããã
ãã¬ãã®ãã¥ãŒã¹ã§ã¯é£æ¥ãCNNã®ã¢ã³ã«ãŒã§ããChris Cuomoæ°ã®ãããªæåäººã®ææè ã®æ§åãäŸãã°ã劻ãéæ®µã®äžã«é£äºãã眮ããåäŸãæãæ¯ã£ãŠåå³ããç¬ãåŒãè¿ããŠããéãéé¢äžã®å°äžå®€ã§äžäººå¥®éããŠãããšãããªã©ãéç ã»ååŸ©ã®æ§åãæŸæ ãããŠããã
ããããCuomoæ°ã§ããããªãWHOãææè ã®èªå® éé¢ã«åŒ·ç¡¬ã«å察ãããã身ã以ãŠç€ºãããšã«ãªã£ãŠããŸã£ããæ°Žææ¥ã«ãCuomoæ°ã¯åŠ»ããŠã€ã«ã¹ã«ææããŠããããšãå ¬è¡šããã®ã ã
ãããæææ¡å€§é²æ¢çãäžã€ææ¡ããªããã°ãªããªããªããããã¯å šãŠã®ææè ã®è¿ éãªéé¢çã ãããããšWHOã®å¯Ÿäžåœãªãã¶ãŒããŒããŒã ãçããBruce Aylwardå士ã¯èšã£ãã
äžåœã§ã¯ãæ€æ»ã§éœæ§ãšå€å®ããã人ã¯ãã©ãã ãçç¶ã軜ããŠãã蚺çæåç é¢ã«å ¥æããããšãæ±ããããããã®ãããªç é¢ã¯ãã°ãã°äœè²é€šãã³ãã¥ããã£ãŒã»ã³ã¿ãŒå ã«é žçŽ ãã¹ã¯ãCTã¹ãã£ããŒãèšçœ®ããŠäœãããã
ããã§ãæ£è ã¯çè·åž«ã«èŠå®ãããªããå埩ããããã®ããšã«ãã£ãŠå®¶æãææããå±éºæ§ãäžãããä»ã®ææè ãšéããããšã§æ£è ã®ææå¿ãåããããã广ããã£ããããã«ãæ£è ãå æ°ã¥ããèºã®ç©ºæ°ãå ¥ãæããçèãåããããã«ãçè·åž«ããã³ã¹ããšã¯ãµãµã€ãºã®ã¯ã©ã¹ãéãããšããã£ãã
äŸç¶ãšããŠããã®ããã«æ£è ã®é颿œèšãèšããããšã«é¢ããŠãå°éå®¶ã®æèŠã¯äºã€ã«å²ããŠãããFinebergå士ã¯ããã¥ãŒãšãŒã¯ã¿ã€ã ãºãžã®å ±åå¯çš¿ã«ãããŠãæ£è ã®éé¢ã¯å¿ é ã§ãããšããããã人ééé¢éçšãã ãšç§°ããã
ããã«å¯ŸããŠãããŒããŒã倧åŠT.H. Chanå ¬è¡è¡ç倧åŠé¢ã®ç«åŠè ã§ããMarc Lipsitchæ°ã¯ããç§ã¯ã¢ã¡ãªã«æ¿åºã匷å¶çã«äººã ãå®¶æããéé¢ããããšããæ¿åºãä¿¡é ŒããŠä»»ããããšã¯ã§ããªããããšå察ããæèŠã衚æããã
究極çã«ã¯ãæææ¡å€§ãæããããã«ã¯ã倿ããŠããå šãŠã®ææè ã®ãå šãŠã®æ¥è§Šè ãæ€æ»ããããšãæ±ãããããããããã¢ã¡ãªã«ã¯å šããã£ãŠãã®å®çŸããã¯çšé ãã
ã¬ã¹ãã©ã³ãå·¥å Žã§åããŠãã人ã«ã¯ãæ°å人ãæãŠã¯æ°çŸäººã®æ¥è§Šè ãååšãããããããªããäŸãšããŠãäžåœã®åå·çã§ã¯ãææè äžäººåœããå¹³åã§45äººã®æ¥è§Šè ããããšããã
CDCã¯çŽ600äººã®æ¥è§Šè 远跡å®ãæããŠãããæè¿ãŸã§ã«ãå·ããã³å°æ¹ã®ä¿å¥å±ã¯ãäž»ãšããŠæ¢ æ¯ããã³çµæ žæ£è ã®æ¥è§Šè ã远跡ããããã«çŽ1600人ãéçšããã
äžåœã¯æŠæŒ¢ã ãã§9000人ãéçšããæ¥è§Šè 远跡å®ãšããŠèšç·ŽãããFriedenåå£«ã®æŠç®ã«ãããšãã¢ã¡ãªã«ã¯å°ãªããšã300,000äººã®æ¥è§Šè 远跡å®ãå¿ èŠã«ãªãã ããã
ã¯ã¯ãã³ã¯ããã«ã¯å®çšåãããªãã ãã
3çš®é¡ã®ã¯ã¯ãã³åè£ïŒã¢ã¡ãªã«2ãäžåœ1ïŒã«å¯Ÿããå°èŠæš¡ãªèšåºè©Šéšããã§ã«å§ãŸã£ãŠããããã¯ã¯ãã³ã®éçºã«ã¯å°ãªããšã1幎ãã18ã¶æçšåºŠã¯å¿ èŠã ããããšFauciå士ã¯ç¹°ãè¿ãè¿°ã¹ãŠããã
ã¯ã¯ãã³éçºã«è©³ããå°éå®¶ã¯ããã®ã¹ã±ãžã¥ãŒã«ã§ããæ¥œèгçã ãšæãã ããããã£ã©ãã«ãã£ã¢å°å ç é¢ïŒCHOPïŒã®ã¯ã¯ãã³ç§åŠè ïŒvaccinologistïŒã§ããPaul Offitå士ã¯ããããµãããã¯ã¯ãã³ã®éçºã«ã¯4幎ããã£ãããšã«èšåããã
ã¯ã¯ãã³ã®éçºãå éãããããã«äœããªãã¹ããã«ã€ããŠã®ç ç©¶è ã®æèŠã¯å€§ããç°ãªã£ãŠãããRNAãDNAãã©ãããã©ãŒã ãçšããçŸä»£ã®ãã€ãªãã¯ãããžãŒæè¡ã«ãããã¯ã¯ãã³åè£ã®éçºãä»ãŸã§ãããéãè¡ãããšãã§ããããã«ãªã£ãã
ããããèšåºè©Šéšã«ã¯æéãããããäžã€ã«ã¯ã人äœå ã§ã®æäœç£çãæ©ããããšãã§ããªãããã ã
ããã«ãåå ã¯ããåãã£ãŠããªãããSARSã®ãããªã³ãããŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³åè£ãæäœäŸåæ§ææå¢åŒ·ïŒæãŠã€ã«ã¹æäœã®ååšã«ãããŠã€ã«ã¹ææãå¢åŒ·ãããçŸè±¡ïŒãåŒãèµ·ãããæ¥çš®ããã人ããŠã€ã«ã¹ã«ææãã«ãããªãã®ã§ã¯ãªããããææãããããªã£ãããšããã£ããéå»ã«ã¯ãHIVã¯ã¯ãã³ããã³ã°ç±ã¯ã¯ãã³ã§äºæ³å€ã«ãåæ§ã®ããšãçºçããã
æ°ããã¯ã¯ãã³ã¯éåžžãæåã«ãè¥ãå¥åº·ãª100人以äžã®ãã©ã³ãã£ã¢ã§è©Šéšããããå®å šã§ããã€æäœãäœãããããã§ããã°ãããã«äœå人ãã®ãã©ã³ãã£ã¢—-æ°åã³ãããŠã€ã«ã¹ã®å Žåã¯æãææãªã¹ã¯ãé«ããå»ççŸå Žãªã©ã®æåç·ã§åã人ãã¡ã«ãªãã ãã—-ãã¯ã¯ãã³åè£ãŸãã¯åœè¬ã®ã©ã¡ãããæäžããã第IIIçžèšåºè©Šéšã«é²ãã ããã
ææŠçèšåºè©ŠéšïŒchallenge trialsïŒãè¡ãã°ã詊éšã®é²è¡ãæ©ããããšãå¯èœã§ãããç ç©¶è ãå°æ°ã®ãã©ã³ãã£ã¢ã«ã¯ã¯ãã³åè£ãæ¥çš®ãããã©ã³ãã£ã¢ãæäœãç£çãããã圌ãããŠã€ã«ã¹ãªã©ã®æåã«ææãããã¯ã¯ãã³åè£ã圌ããææããå®ããã©ããã詊ãïŒchallengeïŒãã®ã ã
ææŠçèšåºè©Šéšã¯ãã©ãªã¢ãè žããã¹ç±ãªã©ãå®å šã«æ²»çããããšã確ãããããŠããææçã«ããè¡ãããªããæ®éã®ç¶æ ã§ããã°ãCovid-19ã®ãããªæ²»çæ³ã®ãªãææçã«å¯ŸããŠææŠçèšåºè©Šéšãè¡ãããšã¯ãå«ççã«ããããªãã
ãããããã®ãããªéåžžäºæ ã«ãããŠã¯ãéãçµæãåŸãããã«å°æ°ã®ã¢ã¡ãªã«äººãé«ããªã¹ã¯ã«æãããšã¯ãæ°çŸäžäººã®ã¢ã¡ãªã«äººãäœå¹Žã«ãããã£ãŠãªã¹ã¯ã«æãç¶ãããããå«ççã ãšäž»åŒµããå°éå®¶ãããã
ãå°äººæ°ã§ã®ææŠçèšåºè©Šéšãè¡ãã°ãäœå人ãå¿ èŠãªç¬¬IIIçžèšåºè©Šéšãè¡ããããã被害ã«éã人ãå°ãªãæžãã ãããããšãJournal of Infectious Diseasesã«ææŠçèšåºè©Šéšãæ¯æããè«æãçºè¡šããã°ããã®Lipsitchå士ã¯è¿°ã¹ãã圌ã«ãããšãããããŸãã©ã³ãã£ã¢ã«å¿é¡ãã人ãçŸãããšããã
ãã®èããéåžžã«äžå¿«ã«æãã人ãã¡ãããããç§ã¯ãã®èãã¯ãšãŠãéå«ççã ãšæããã§ãæã ããã®ãããªããšã«æãæããå¯èœæ§ãããããšã¯çè§£ã§ãããããšLuceyå士ã¯è¿°ã¹ãã
ã¯ã¯ãã³ç§åŠè ã®èª¬æã«ãããšãææŠçèšåºè©Šéšã®é ããå±éºæ§ã¯ãåéãããã©ã³ãã£ã¢ã®æ°ãå°ãªãããŠãã¯ã¯ãã³ãåé¡ãªãè¯ã广ããããããã©ãããæããã«ããããšãã§ããªãããšã ãã¯ã¯ãã³æ¥çš®ã«ããé倧ãªå¯äœçšã¯çšãããããªãããå±éºãªåé¡ã§ããããã ã
ãææŠçèšåºè©Šéšã§ã¯ã¯ã¯ãã³ãå®å šãã©ãã確ãããããšã¯ã§ããªããããšãããœã¿å€§åŠææçç ç©¶æ¿çã»ã³ã¿ãŒé·ã®Michael T. Osterholmæ°ã¯èšãããããã倧åé¡ã«ãªããããããªããã
ã³ãã³ãã¢å€§åŠå ¬è¡è¡ç倧åŠé¢ïŒMailman School of Public HealthïŒã®ãŠã€ã«ã¹åŠè ã§ããW. Ian Lipkinå士ã¯ãå¥ã®æŠç¥ãææ¡ããŠãããå°ãªããšãïŒçš®é¡ã®ã¯ã¯ãã³åè£ãéžã³ã人ã§ç°¡æçãªè©Šéšãè¡ã£ãã®ã¡ãææŠçèšåºè©Šéšããµã«ã§è¡ããšãããã®ã ãææãªã¯ã¯ãã³åè£ã®çç£ãå³åº§ã«ãããã«ã¯èŠã€ãã«ããåé¡ç¹ãæ¢ãããã«äººã§ã®æ€æ»ãæ¡å€§ããŠããæéã«ãå§ããããšãã§ããã
ã¯ã¯ãã³ã®è©Šéšãé£èªããã°ããã»ã©ãäœåååãã®æäžéã®ã¯ã¯ãã³ãçç£ããããšã¯ããäžå±€é£ãããªãããšå°éå®¶ã¯ææããŠããã
倧éšåã®ã¢ã¡ãªã«ã®ã¯ã¯ãã³å·¥å Žã¯å¹Žéãã£ã500äžã1000äžååã®ã¯ã¯ãã³ããçç£ã§ããããããã®ã»ã©ãã©ã¯æ¯å¹Ž400äžäººã®ä¹³å ãš400äžäººã®65æ³ã«ãªã人ã®ããã«å¿ èŠã ããšè£œè¬ã¡ãŒã«Merckã®åã¯ã¯ãã³éšéé·ã§ããR. Gordon Douglas Jr.å士ã¯è¿°ã¹ãã
ããããããæ°åã³ãããŠã€ã«ã¹çšã®ã¯ã¯ãã³ãéçºãããããã¢ã¡ãªã«ã§ã¯äžåã®æ¥çš®ã§æžãã ãšããŠã3åååã®ã¯ã¯ãã³ããäºåã®æ¥çš®ãå¿ èŠãªã6åååã®ã¯ã¯ãã³ãå¿ èŠã«ãªãã ãããããã«åãæ°ã®æ³šå°åšãå¿ èŠã ã
ã人ã ã¯å€§å±çãªèŠç¹ãæã€ã¹ãã ãããšDouglaså士ã¯èšãããããã ã倧éã«å¿ èŠãªããè¿ããã¡ã«ã©ãã©ãçç£ãå§ããªããã°ãªããªããã
ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³å·¥å Žã¯å€§èŠæš¡ã ããé¶åµã§å¹é€ãããåç©åäœå¹é€ã¯ã¯ãã³ã®å·¥å Žã¯ã现èå¹é€æè¡ãçšããçŸä»£ã¯ã¯ãã³ã®çç£ã«ã¯åããªãããšå士ã¯èšãã
欧å·è«žåœã¯ã¯ã¯ãã³å·¥å Žãæã£ãŠããããããã§çç£ãããã¯ã¯ãã³ã¯èªåœæ°ã®ããã«å¿ èŠã ãããäžåœã¯å€§èŠæš¡ãªã¯ã¯ãã³ç£æ¥ãæã£ãŠãããä»åŸããã«èŠæš¡ãæ¡åŒµã§ãããããããªããã¢ã¡ãªã«ã«èŒžåºããããã®ã¯ã¯ãã³ãçç£ã§ãããããããªãããšå°éå®¶ã¯èšããããããä»ã«éžæè¢ã®ãªãè²·ãæã¯å£²ãæã®èšãå€ãæ¯æããããªããäžéšã®äžåœäŒæ¥ã®å®å šæ§ãšæå¹æ§ã®åºæºã¯äžååã§ããã
ã€ã³ããšãã©ãžã«ããŸãå€§èŠæš¡ãªã¯ã¯ãã³ç£æ¥ãæããŠãããææããããã®åœã®äººå£å¯éå°åã®äººã ã®éã§åºããã°ãæ°çŸäžäººã®äººã ã亡ããªãã ããããã¢ã¡ãªã«ããããã£ãšå ã«å€§èŠæš¡ãªéå£å ç«ãç²åŸãããããããªãããããªãã°ãã¯ã¯ãã³å·¥å Žã«ä»åœã«èŒžåºã§ãããããªäœåãçãŸãããããããªãã
ãããã¯ããžã§ã³ãºã»ãããã³ãºå€§åŠå»åŠéšãåŒéããå»åŠæŽå²å®¶ã§ããArthur M. Silversteinæ°ã瀺åããããã«ãçºé µçšã®å€§ã ããåããŠããèžçé å·¥å ŽãããŒã«å·¥å Žãæ¿åºãæ¥åã»æ¶æ¯ããããšãããåŸããããããªãã
ãèžçé è£œé æãããšããšãã¯ã¯ãã³å·¥å Žã«è»¢çšããããããããªããããšåœŒã¯èšã£ãã
æ²»çæ³ã®æ¹ãã¯ã¯ãã³ãããå ã«éçºããããã
çæçã«ã¯ãå°éå®¶ã¯ã¯ã¯ãã³ã®éçºãããæ²»çæ³ã®éçºã«å¯ŸããŠããæ¥œèгçãªèŠæ¹ãããŠãããäžã§ããããããå埩æè¡æž ïŒconvalescent serumïŒãææã ãšããèŠè§£ãããã
ãã®åºæ¬çãªææ³ã¯äžäžçŽä»¥äžã«æž¡ã£ãŠçšããããŠãããææçããå埩ãã人ã®è¡æ¶²ãæ¡åããæäœä»¥å€ã®å šãŠã®ãã®ãåãé€ãããããŠæäœãè±å¯ã«å«ãã å ç«ã°ãããªã³ãæ£è ã«æ³šå°ããã
å®çšåãžã®é害ã¯ãçŸæç¹ã§ã¯è¡æ¶²ãæ¡åã§ããææããã®å埩è ãæ¯èŒçå°ãªãããšã ã
ã¯ã¯ãã³ãäžè¬åããåã®æä»£ã«ã¯ãæäœã¯éЬãçŸã®äœå ã§äœãããŠããããããããã®éçšãç¡èã«ä¿ã¡ç¶ããããšã¯é£ãããåç©ç±æ¥ã®ã¿ã³ãã¯è³ªãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããããšããã£ãã
çŸä»£ã§ã¯ããã«ä»£ãããã®ãšããŠã¢ãã¯ããŒãã«æäœãçšããããããã®æ²»çæ¹åŒã¯ãè¿å¹Žã§ã¯ã³ã³ãŽæ±éšã®ãšãã©æµè¡ãã»ãŒçµæ¯ãããææãäžããŠãããçæçã«èŠãå Žåãæã驿°çãªæ²»çæ³ãšãªãåŸãã®ã§ã¯ãªããããšå°éå®¶ã¯è¿°ã¹ãã
æãæå¹ãªæäœãéžã°ãããã®æäœãäœãããã®éºäŒåã现èå¹é€æ¶²ã®äžã§å¢æ®ããè¯æ§ãŠã€ã«ã¹å ã«çµã¿èŸŒãŸããã
ããããã¯ã¯ãã³ãšåæ§ã«ãã¢ãã¯ããŒãã«æäœãç£çããäžçŽç©ãåãé€ãã®ã«ã¯æéãããããçè«äžã¯ãååãªçç£éã確ä¿ã§ããã°ãåœãå®ãããã ãã§ã¯ãªããå»çåŸäºè ãªã©ææãªã¹ã¯ã®é«ãçŸå Žã§åã人ã ã®ææãé²ãããã«äœ¿çšããããšãã§ããã ããã
æäœã¯å£ããããŸã§æ°é±éååšãã–Silversteinå士ã«ãããšæäœã®åç¶æéã¯æ§ã ãªèŠå ã«å·Šå³ããã–ããæäœã¯ãã§ã«çްèå ã«å ¥ã蟌ãã ãŠã€ã«ã¹ã殺ãããšã¯ã§ããªãã
å·¥å Žã§è¬ãåæããŠäœãæ¹ããã¯ã¯ãã³ãæäœãç£çããäžçŽç©ãé€å»ãããããã£ãšéãã¹ããŒãã§ã§ããã®ã§ãæ¯æ¥äºé²è¬ãé£²ãæ¹ãè¯ã解決çã«ãªãåŸãã®ãããããªãã
ãããããããã®ãããªäºé²è¬ãéçºããããšããŠããã¢ã¹ããªã³ã®ããã«ã©ãã§ãæã«å ¥ãããã«ãªã£ãŠ3å人ã®ã¢ã¡ãªã«äººãæ¯æ¥äœ¿çšã§ããããã«ãªããŸã§ãçç£éãæ¡å€§ãã€ã¥ããªããã°ãªããªãã ããã
ãã©ã³ã倧統é ãããããã·ã¯ãããã³ãšã¢ãžã¹ããã€ã·ã³ã«äœåºŠãèšåãããããèšè äŒèŠãã©ã€ãã³ããŒã·ã£ã«ã®ããã«ãªã£ãŠãããããããèšåºè©ŠéšãçµãããŸã§çµè«ãäžãã¹ãã§ã¯ãªããšããFauciåå£«ã®æèŠã«å šãŠã®å°éå®¶ãè³æããŠããã
ãµãªããã€ãã®è©Šéšãäžååã ã£ãããã«ã1950幎代ã«äœå人ãã®åäŸã«ã¢ã¶ã©ã·è¢çãªã©ã®åè¢å¥åœ¢ãåŒãèµ·ããããããšãæãèµ·ããã人ãããã ãããé«çšéã®ããããã·ã¯ãããã³ãæäžãããæ£è ã«å¿æç°åžžãèŠããããããè€æ°ã®ããããã·ã¯ãããã³ã«é¢ããç ç©¶ãäžæ¢ãããã
ãç§ã¯èª°ããé«çšéã®æäžã«èãããããšã¯æããªããããã«ããããã·ã¯ãããã³ãäœå ã«èç©ãããšãèŠåã«åé¡ãçããããšããããããšBarryå士ã¯èšã£ãããã§ãPrEPïŒæé²åäºé²å æïŒã®ãããªå¹æããããã©ããã¯è峿·±ããããšãHIVææãäºé²ããããã«çšããããè¬ã«èšåããªããä»ãå ããã
ç¹ã«ã¯ãããã³ãšã¢ãžã¹ããã€ã·ã³ã䜵çšãããšãããã©ã³ã倧統é ã®èãã«å¯ŸããŠå³ããæèŠãè¿°ã¹ãè ãããã
ãå®å šã«éŠ¬é¹¿ããŠãããããšåœå®¶å®å šä¿éäŒè°ã®å»çããã³çç©å µåšé²åŸ¡æºåå±åå±é·ã§ããLuciana Borioå士ã¯èšã£ãããç§ã¯å®¶æã«ããç§ãCOVID-19ã«ææããŠããã¯ãããã³ãšã¢ãžã¹ããã€ã·ã³ã®çµã¿åããã¯æäžããªãã§ã»ãããšèšã£ãŠããããã
ã¯ãããã³ã¯å ç«åå¿ã匱ãããããèŽæ»çãªãµã€ãã«ã€ã³ã¹ããŒã ã«ããèºçã§å ¥é¢ããŠããæ£è ã®æ²»çã«åœ¹ç«ã€ãããããªãããšè¿°ã¹ãå»åž«ãããã
ããããªãããã¯ãããã³ã«æãŠã€ã«ã¹äœçšãããããšã¯ç¢ºèªãããŠããªãããããã©ã³ã倧統é ã广ãã»ã®ããããŠããã®ãšã¯ç°ãªããã¯ãããã³ã®äœ¿çšã¯ææãé²ãã®ã«æå¹ã§ããããã§ã¯ãªãã
ã¬ã ãã·ãã«ããã¡ããã©ãã«ãããããµãã«ãå«ãæ°çš®é¡ã®æãŠã€ã«ã¹è¬ããæ°åã³ãããŠã€ã«ã¹ã«å¯Ÿãã广ã詊éšãããŠãããåŸããã2ã€ã¯ã€ã³ãã«ãšã³ã¶è¬ã§ããã
äžåœã§è¡ãããæ§ã ãªè¬ã®äœµçšè©Šéšã®çµæãæ¥æãŸã§ã«å ¬è¡šãããã ããããããã詊éšã§ããæ£è ãè¶³ããªããªã£ãããã«ããããã®è©ŠéšèŠæš¡ã¯å°ãããçµè«ãåºãªããŸãŸçµãã£ãå¯èœæ§ããããã¢ã¡ãªã«ã§è¡ãããŠãã倧éšåã®èšåºè©Šéšã®çµäºæ¥ã¯ããŸã å®ããããŠããªãã
ããã°ãã¢ã¡ãªã«ã»ãã¡ãŒã¹ãã
以åã«ã¯èããããªãã£ããããªç€ŸäŒçå€åããã§ã«èµ·ãã£ãŠããŸã£ãŠãããåŠæ ¡ãäŒç€Ÿã¯å šãŠã®å·ã§ééãããŠãããäœåäžäººãã倱æ¥ä¿éºãç³è«ãããçšéãäœå® ããŒã³ã®æ¯æãã¯ç¶äºãããæµåœæµãã¯çŠæ¢ãããã
ä»é±ãããã®å±æ©ãä¹ãè¶ããããã®çµŠä»éãåœåº§é éå£åº§ãžæ¯ã蟌ãŸãå§ããã¢ã¡ãªã«ãäžæçã«çŠç¥åœå®¶è¶³ããããŠãããå šåœçã«ããŒããã³ã¯ã«ããæŽ»åãè¡ãããŠããããã®é 絊ã«ã¯é·èã®åãã§ããŠããã
åœéçãªé£æºãå¿ èŠãšããã»ã©å€§èŠæš¡ã®å ¬è¡è¡çäžã®å±æ©ã¯ãããæ°å幎éã§çµéšããããšã®ãªããã®ã ããããããã©ã³ã倧統é ã¯ããã®ãããªäºæ ã«ãããŠåœéçãªé£æºãä¿ãããšãã§ããå¯äžã®çµç¹ã§ããWHOãžã®æ åºéã忢ããåããèŠããŠããã
ããã«ä»å¹Žã«å ¥ã£ãŠãã©ã³ã倧統é ã¯ãä»ãšãªã£ãŠã¯äžçã§æãå¢ãã®ãã忢ããŠããªãçµæžãèªããå»è¬åãã¯ã¯ãã³ã®æãæåãªäŸçµŠè ã«ãªãåŸãäžåœã«å¯Ÿããæµæãããåºãã«ããŠãããäžåœã¯ãã®ææççºãèªåœã®åœéçãªåœ±é¿åãæ¡å€§ããããã«å©çšããå»çæ©åšãå»ççšåã120ã¶åœè¿ãã«æ¯æŽãããšäž»åŒµããŠããã
äžåœããæãå€ãã®æ¯æŽãåãããã¡ã®äžã¶åœãã¢ã¡ãªã«ã§ãããããã«ããã¯ãProject Airbridgeãšããããã©ã³ã倧統é ã®åšå©¿ã§ãããžã£ã¬ããã»ã¯ã·ã¥ããŒæ°ã®åœ±é¿äžã«ããèªç©ºè²šç©éè¡æ©é¢ãéããŠè¡ãããã
ãã®äžçã§ã¯ãã¢ã¡ãªã«ã»ãã¡ãŒã¹ããã¯å®è¡äžå¯èœã ããšè€æ°ã®å°éå®¶ãè¿°ã¹ãŠããã
ããããã©ã³ã倧統é ãã¢ã¡ãªã«ã«ãããå ¬è¡è¡ç掻åãä¿é²ããããªããäžåœãšå調ããéãæš¡çŽ¢ãã䟮蟱çãªèšåãæ ãã¹ãã ãããšã³ãŒãã«å€§åŠã®çµæžå²å®¶ã§ããNicholas Mulderæ°ã¯è¿°ã¹ãã圌ã¯ã¯ã·ã¥ããŒæ°ã®ãããžã§ã¯ãããç¬¬äºæ¬¡äžç倧æŠäžã®ä»åœã«å¯Ÿããã¢ã¡ãªã«è»ã®æŽå©ã«ãªããããŠãéã¬ã³ããªãŒã¹ããšç§°ããã
Osterholmå士ã¯ãã£ãšçŽçã ã£ãããã¢ã¡ãªã«è³äžäž»çŸ©ã®èãã«åºã¥ããŠäžåœãææ¥ããã°ãäžåœã¯åŸã ã¢ã¡ãªã«ã«åŸ©è®ãã«æ¥ãã ãããããšè¿°ã¹ãã
ãããäžåœãæåã«ã¯ã¯ãã³éçºã«æåãããïŒã©ã®åœã«ã¯ã¯ãã³ã売ããã®éžææš©ã¯äžåœã«ãããã¢ã¡ãªã«ãã¯ã¯ãã³å£²åŽå ãªã¹ãã®æäžäœã«äœçœ®ããŠãããšã§ãæã£ãŠããã®ãïŒãŸãããããªããããªãïŒã
ã²ãšãã³ææçã®æµè¡ãçµæ¯ããã°ãã¢ã¡ãªã«ã®åœåã¯è¿ éã«å埩ãããããããªããMulderå士ã¯ãäºåºŠã®äžç倧æŠåŸã«çµæžãåäžæããããšã«èšåããã
å¿çç¶æ ã®æªåã«ããåŸéºçã®å®æ ã¯ãããäžå±€ææ¡ããããšãé£ãããé·æã«ãããææ¥åæ¢ã«ãã£ãŠããããããå€ç«åãšè²§å°ããå®¶åºå æŽåã鬱ç ãèªæ®ºã®å²åãäžæããããããããªãã
æ¿æ²»çãªèãæ¹ãŸã§å€åããå¯èœæ§ããããåœåãã·ã¢ãã«ããã¥ãŒãšãŒã¯ããããã€ããªã©ã®æ°äž»éœåžã§æææ¡å€§ãæ¿ããã£ãããããããŠã€ã«ã¹ãå šåœçã«åºããã«ãããã£ãŠãèª°ãææããéããããªããªãã ããã
æ°åã³ãããŠã€ã«ã¹ã«å¯Ÿããæºåäžè¶³ãå¥åº·ä¿éºãžã®å å ¥ãå¶éãããŠããããšã«é¢ããŠã¯ãã©ã³ãæ¿æš©ãéé£ããªãå ±åå å¯ãã®å·ã®ææš©è ã§ãããå人ãè¿èŠªè ã亡ããªãã®ãç®ã®åœããã«ãããèããå€ãããããããªãã
Pueyoæ°ã¯ãCoronavirus: Out of Many, Oneããšãã远跡調æ»èšäºå ã§ãä»åéœåžå°éã«æµæããå·å ã§ããã€2016幎ãå ±åå ã«æç¥šããé¡ã«ããããå»çä¿éºå¶åºŠãšåœå¢èª¿æ»ã®ããŒã¿ã幎霢ãšè¥æºåºŠå¥ã«åæããç©è°ãéžããã
åœŒã®æšå®ã«ãããšãéœåžå°éã«æµæããå·å ã®å ±åå ãžã®æç¥šè ã¯ãããã§ãªã人ããããæ°åã³ãããŠã€ã«ã¹ã§æ»äº¡ããå¯èœæ§ã30ïŒ é«ããªããšããã
äºåºŠã®å€§æŠåŸã®æéã«ã瀟äŒãšåå ¥ã¯ããå¹³çã«ãªã£ããšãMulderå士ã¯èšåããã瀟äŒçã»ãŒããã£ãŒãããã«ã€ãªããé圹è»äººã倫ã亡ããã女æ§ã®å¹Žéã®ããã®åºéãèšç«ããã埩å¡è»äººæŽè·æ³ãé圹è»äººäœå® ããŒã³æ³æ¡ãæ¡æãããåŽåçµåã¯åŒ·åã«ãªããå¯è£å±€ã«å¯Ÿããçšå¶äžã®åªéæªçœ®ã¯æžã£ãŠãã£ãã
ããã¯ã¯ãã³ã人ã ã®åœãæãã°ãå€ãã®ã¢ã¡ãªã«äººãäŒçµ±å»åŠãããä¿¡é Œããããã«ãªããæ°åã®å€åãå«ãç§åŠå šè¬ãããåãå ¥ããããã«ãªããããããªãããšå°éå®¶ã¯èšãã
ä»åã®éœåžå°éã®æéäžã«ã¢ã¡ãªã«éœåžéšã®äžç©ºã«åºçŸããé空ããå°éè§£é€åŸãæ°žé ã«ç¶ããããªæªæ¥ãããããã®ãããããªãã
翻蚳å èšäº